P-3 PIRFENIDONE PREVENTS OBESITY-ASSOCIATED NONALCOHOLIC STEATOHEPATITIS AND CARDIAC FIBROSIS THROUGH HORMONAL REPROGRAMMING Jorge Gutiérrez; Daniel López; Ana Soledad Sandoval; Ángel Omar Vázquez; Jonathan Samael Rodríguez; Juan Armendáriz;

P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST. Samael Rodríguez; Rebeca Rosas; Angel Omar Vazquez; Ivonne Palacios; Ricardo De la Rosa; Rebeca Escutia; Josep Jiménez; Luis Felipe Jave; Arturo Santos; Ana Sandoval; Juan Armendariz;

P- 25 METABOLIC, HISTOLOGICAL AND INFLAMMATORY BENEFITS IN A MURINE MODEL OF ALCOHOLIC STEATOHEPATITIS USING METHYL-GROUP DONOR SUPPLEMENTATION Carolina Diaz; Angel Omar Vázquez; Rebeca Rosas; Samael Rodriguez; Rebeca Escutia; Marina Galicia; Juan Armendariz; Ana Sandoval;